SGLT2i-induced euglycemic diabetic ketoacidosis in a heart failure patient with acute myocardial infarction: a case report
Although the early use of SGLT2i may improve cardiac function in patients with AMI and heart failure, our findings suggest that clinicians should be aware of the association between SGLT2i therapy and euDKA. SGLT2i should be avoided in acute cardiovascular crises until patient stabilization.
Authors
- Chi Zhou (ORCID: https://orcid.org/0000-0001-7358-2062)
- Jin Huang (ORCID: https://orcid.org/0000-0002-8154-942X)
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1097/ms9.0000000000003750
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29